Item 6. Exhibits

The following documents are filed as a part of this Quarterly Report:


Exhibit						Description
EXHIBIT 3.1						Amended Articles of Incorporation are incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed on May 4, 2022

EXHIBIT 3.2						Bylaws, as amended, are incorporated by reference to Exhibit 3.2 to the Company's Current Report on Form 8-K filed on May 4, 2022

EXHIBIT 10.1						Form of Performance Award under the 2002 Lilly Stock Plan (with non-compete)(1)

EXHIBIT 10.2						Form of Shareholder Value Award under the 2002 Lilly Stock Plan (with non-compete)(1)

EXHIBIT 10.3						Form of Relative Value Award under the 2002 Lilly Stock Plan (with non-compete)(1)

EXHIBIT 31.1						Rule 13a-14(a) Certification of David A. Ricks, Chair, President, and Chief Executive Officer

EXHIBIT 31.2						Rule 13a-14(a) Certification of Anat Ashkenazi, Executive Vice President and Chief Financial Officer

EXHIBIT 32.						Section 1350 Certification

EXHIBIT 101.						Interactive Data Files (embedded within the Inline XBRL document)

EXHIBIT 104.						Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

(1) Indicates management contract or compensatory plan.

Long-term debt instruments under which the total amount of securities authorized does not exceed 10 percent of our consolidated assets are not filed as exhibits to this Quarterly Report. We will furnish a copy of these agreements to the Securities and Exchange Commission upon request.

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.


		ELI LILLY AND COMPANY
		(Registrant)

Date:	November 1, 2022	/s/ Anat Ashkenazi
		Anat Ashkenazi
		Executive Vice President and Chief Financial Officer
Date:	November 1, 2022	/s/ Donald A. Zakrowski
		Donald A. Zakrowski
		Senior Vice President, Finance, and Chief Accounting Officer

Previous: Item 1A. Risk Factors